Cancer risks from germline p53 mutations.
Open Access
- 1 November 1992
- journal article
- review article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 90 (5) , 1637-1641
- https://doi.org/10.1172/jci116034
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Abnormal expression of wild type p53 protein in normal cells of a cancer family patientThe Lancet, 1992
- The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationCell, 1992
- Definition of a consensus binding site for p53Nature Genetics, 1992
- Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumoursNature, 1992
- TP53 tumor suppressor gene: A model for investigating human mutagenesisGenes, Chromosomes and Cancer, 1992
- p53 germline mutations in Li-Fraumeni syndromeThe Lancet, 1991
- p53 Mutations in Human CancersScience, 1991
- The p53 tumour suppressor geneNature, 1991
- Mutation and Cancer: Statistical Study of RetinoblastomaProceedings of the National Academy of Sciences, 1971
- Suppression of Malignancy by Cell FusionNature, 1969